InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 17.19
+0.47 (2.81%)
At close: Jun 18, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 9.94 billion as of June 18, 2026. Its market cap has decreased by -27.53% in one year.
Market Cap
9.94B
Enterprise Value
8.58B
Revenue
71.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.19
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 9.94B, an increase of 13.08%. That is a compound annual growth rate of 3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.94B | -36.89% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 11.95B |
| Tibet Cheezheng Tibetan Medicine | 11.12B |
| HitGen | 11.03B |
| Inner Mongolia Furui Medical Science | 10.63B |
| Chengzhi | 10.51B |
| Jiangxi Fushine Pharmaceutical | 10.49B |
| Pacific Shuanglin Bio-pharmacy | 10.27B |
| Hualan Biological Vaccine | 9.81B |